NRC
NRC
US6373722023
NRC Health
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 40/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.3x).

Beta (Market Relation)
0.28x
Defensive
Volatility (5Y p.a.)
43.1% p.a.
5-Year Horizon
Max Drawdown (5Y)
-79.3%
5-Year Horizon
Sharpe Ratio
-0.38
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — +71.3%
3 Years 48.6% -77.6% -0.53 -23.3%
5 Years 43.1% -79.3% -0.38 -13.7%
10 Years 40.8% -85.6% 0 +2.6%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 1381%.
🔴 High valuation risk: Avg P/E of 84.7 (Elevated multiple compression risk)
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Elevated Short-Term Volatility: 3Y volatility (48.6%) is noticeably higher than the 5Y average (43.1%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (43.1% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -85.6% in the extended horizon.

Corporate Governance & ISS Scores

Shareholder rights, board structure and audit safety (Scale 1 = Low Risk, 10 = High Risk)
Overall Governance Risk
6 ISS Score: 6 / 10
Audit Risk
7 ISS Score: 7 / 10
Board Risk
7 ISS Score: 7 / 10
Short Ratio
5.79
ende